Pure Bioscience Inc Revenue Growth Rates (PURE), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Pure Bioscience Inc   (PURE)
 

PURE's Revenue Growth by Quarter and Year

Pure Bioscience Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/PURE/growth
https://api.csimarket.com/api/v1/companies/PURE/fundamentals
https://api.csimarket.com/api/v1/companies/PURE/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
PURE Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter July 0.66
3rd Quarter April 0.51
2nd Quarter January 0.44
1st Quarter October 0.71
FY 2.32

PUREs Annual Revenue
Pure Bioscience Inc 's Revenue in the fiscal year 2026 $ 2.32 millions
Pure Bioscience Inc 's Revenue in the fiscal year 2025 $ 2.20 millions
Pure Bioscience Inc 's Revenue in the fiscal year 2024 $ 1.96 millions
Pure Bioscience Inc 's Revenue in the fiscal year 2023 $ 1.88 millions
Pure Bioscience Inc 's Revenue in the fiscal year 2022 $ 1.85 millions




PURE Revenue fourth quarter 2025 Y/Y Growth Comment
Pure Bioscience Inc reported fall in Revenue in the fourth quarter 2025 by -13.29% to $ 0.66 millions, from the same quarter in 2024.
The decline in the fourth quarter 2025 Pure Bioscience Inc 's Revenue compares unfavorably to the Company's average Revenue jump of 53.33%.

Looking into fourth quarter 2025 results within Chemical Manufacturing industry 31 other companies have achieved higher Revenue growth. While Pure Bioscience Inc ' s Revenue decrease of -13.29% ranks overall at the positon no. 2315 in the fourth quarter 2025.


PURE Revenue ( Y/Y Growth %) 2025
 FY 2024 FY 2023 FY 2022
4th Quarter July -13.29 %
3rd Quarter April 4.08 %
2nd Quarter January 12.82 %
1st Quarter October 26.79 %
FY   5.41 %

Financial Statements
Pure Bioscience Inc 's fourth quarter 2025 Revenue $ 0.66 millions PURE's Income Statement
Pure Bioscience Inc 's fourth quarter 2024 Revenue $ 0.76 millions Quarterly PURE's Income Statement


PURE Revenue (Quarter on Quarter Growth %)

 2025
 FY 2024 FY 2023 FY 2022
4th Quarter July 29.22 %
3rd Quarter April 15.91 %
2nd Quarter January -38.03 %
1st Quarter October -6.58 %
FY (Year on Year)   5.41 %


Back to PURE Growth rate Comparisons >> Back to PURE Growth rate Comparisons >>


Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Chemical Manufacturing Industry #32
Basic Materials Sector #130
Overall #2315

Revenue Y/Y Growth Statistics
High Average Low
611.86 % 53.33 % -84.41 %
(Jul 31 2020)   (Jul 31 2022)
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Chemical Manufacturing Industry #32
Basic Materials Sector #130
Overall #2315
Revenue Y/Y Growth Statistics
High Average Low
611.86 % 53.33 % -84.41 %
(Jul 31 2020)   (Jul 31 2022)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Pure Bioscience Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
536.59 % 27.22 % -100 %
(Apr 30 2014)  


PURE's IV. Quarter Q/Q Revenue Comment
Pure Bioscience Inc achieved in the IV. Quarter 2025 above company average sequential Revenue jump of 29.22%, to $ 0.66 millions, from $0.51 millions in the third quarter.

Within Chemical Manufacturing industry 13 other companies have achieved higher Revenue quarter on quarter growth. While Pure Bioscience Inc 's Revenue growth quarter on quarter, overall rank is 617.


Revenue Q/Q Growth Company Ranking
Within: No.
Chemical Manufacturing Industry #14
Basic Materials Sector #46
Overall #617
Revenue Q/Q Growth Company Ranking
Within: No.
Chemical Manufacturing Industry #14
Basic Materials Sector #46
Overall #617
Revenue Q/Q Growth Statistics
High Average Low
536.59 % 27.22 % -100 %
(Apr 30 2014)  


PURE's IV. Quarter Q/Q Revenue Comment
Pure Bioscience Inc achieved in the IV. Quarter 2025 above company average sequential Revenue jump of 29.22%, to $ 0.66 millions, from $0.51 millions in the third quarter.

Within Chemical Manufacturing industry 13 other companies have achieved higher Revenue quarter on quarter growth. While Pure Bioscience Inc 's Revenue growth quarter on quarter, overall rank is 617.


Pure Bioscience Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jul 31 2026)		 12 Months Ending (Apr 30 2026) 12 Months Ending (Jan 31 2026) 12 Months Ending (Oct 31 2025) 12 Months Ending (Jul 31 2025)
Cumulative Revenue 12 Months Ending $ 2.32
Y / Y Revenue Growth (TTM) 5.22 %
Year on Year Revenue Growth Overall Ranking # 2813
Seqeuential Revenue Change (TTM) -4.34 %
Seq. Revenue Growth (TTM) Overall Ranking # 2080


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jul 31 2026 period, Pure Bioscience Inc 's cumulative twelve months Revenue were $ 2 millions, company would post below average annual Revenue growth of -4.34% year on year, if the fiscal year would end at Jul 31 2026.
A slow-down in the Pure Bioscience Inc 's Revenue growth from the 0.51% growth in Apr 30 2026.

In the Basic Materials sector 172 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2726 to 2813.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Chemical Manufacturing Industry # 30
Basic Materials Sector # 173
Overall # 2813

Revenue TTM Y/Y Growth Statistics
High Average Low
262.34 %
 21.2 %
-52.81 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 117
S&P 500 # 2080
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jul 31 2026 period, Pure Bioscience Inc 's cumulative twelve months Revenue were $ 2 millions, company would post below average annual Revenue growth of -52.81% year on year, if the fiscal year would end at Jul 31 2026.
A slow-down in the Pure Bioscience Inc 's Revenue growth from the 0.51% growth in Apr 30 2026.

In the Basic Materials sector 172 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2726 to 2813.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Chemical Manufacturing Industry # 30
Basic Materials Sector # 173
Overall # 2813

Revenue TTM Y/Y Growth Statistics
High Average Low
262.34 %
21.2 %
-52.81 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 117
S&P 500 # 2080




Other Revenue Growth
Chemical Manufacturing Industry Revenue Growth Trends and Statistics
Basic Materials Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PURE's Revenue Growth Ratio versus Chemical Manufacturing Industry, Basic Materials Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Jul 31 2026 within Basic Materials SectorY/Y Change %Revenue for the quarter ending Jul 31 2026
Northern Minerals and Exploration Ltd -10.83%$ -10.829 millions
Pure Bioscience Inc -13.74%$ -13.743 millions
Mesabi Trust-55.76%$ -55.761 millions


About Pure Bioscience Inc Revenue Growth Rates (PURE), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Pure Bioscience Inc (CIK 1006028).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-26-049272
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Pure Bioscience Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.